ArticleJournal of internal medicine2022

Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT-AML trial.

Martin Jädersten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.